| |
| |
|
| Insider
Information: |
Danos Olivier |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
124,853 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,965,186 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
124,853 |
|
|
| Total
Value |
$1,965,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regenxbio Inc. |
RGNX |
|
2024-01-02 |
124,853 |
2018-10-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
38,462 |
124,853 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2024-01-02 |
4 |
D |
$17.95 |
$150,960 |
D/D |
(8,410) |
86,391 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2023-06-30 |
4 |
A |
$16.99 |
$19,081 |
D/D |
1,123 |
94,801 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
65,930 |
92,950 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2023-01-03 |
4 |
D |
$22.68 |
$46,675 |
D/D |
(2,058) |
27,020 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2022-06-30 |
4 |
A |
$21.00 |
$15,284 |
D/D |
728 |
93,678 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,700 |
29,078 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2022-01-01 |
4 |
D |
$32.70 |
$39,927 |
D/D |
(1,221) |
18,378 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2021-12-31 |
4 |
A |
$27.80 |
$28 |
D/D |
1 |
19,599 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2021-06-30 |
4 |
A |
$33.02 |
$18,327 |
D/D |
555 |
19,598 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,600 |
19,043 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2020-06-30 |
4 |
A |
$31.31 |
$20,067 |
D/D |
641 |
7,443 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2019-12-31 |
4 |
A |
$34.82 |
$10,517 |
D/D |
302 |
6,802 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2019-04-15 |
4 |
AS |
$52.23 |
$105,320 |
D/D |
(2,000) |
6,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2019-04-15 |
4 |
OE |
$20.35 |
$40,700 |
D/D |
2,000 |
8,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2019-03-12 |
4 |
OE |
$20.35 |
$101,750 |
D/D |
5,000 |
6,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
OE |
$20.35 |
$30,525 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2018-10-08 |
4 |
AS |
$62.79 |
$1,275,914 |
D/D |
(20,000) |
0 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Scientific Officer |
• – – |
2018-10-08 |
4 |
OE |
$20.35 |
$407,000 |
D/D |
20,000 |
20,000 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
